Custom Search Insider Trading Activity Insider Trading Activity
Attention insiders: Dive deeper into market movements and stay ahead of the curve with Benzinga Pro! From up-to-the-second news to audio squawks and interactive data tools, it's everything you need to supercharge your trading strategy. Experience the Benzinga Pro advantage today and transform the way you trade with our exclusive free trial!
Custom Search Insider Trading Activity
Updated Jul 5, 2017
Ticker
|
Company Name
|
Qty.
|
Price
|
Size ($)
|
Filing Date
|
Type
|
Δ Own
|
Own
|
Insider Names
|
Title
|
Trade Dates
|
Is Scheduled
| |
---|---|---|---|---|---|---|---|---|---|---|---|---|---|
Juniper Pharmaceuticals Inc
| 8.91K |
—
|
—
| +44.71% | 28.84K |
Jun 30
| |||||||
Juniper Pharmaceuticals Inc
| 1.62K |
$6.16 | $9,994.27 | +8.87% | 19.93K |
Aug 23
| |||||||
Juniper Pharmaceuticals Inc
| 6.06K |
—
|
—
| +49.54% | 18.3K |
Aug 2
| |||||||
Juniper Pharmaceuticals Inc
| 2.53K |
—
|
—
| +26.04% | 12.24K |
Oct 28
| |||||||
Juniper Pharmaceuticals Inc
| 1.25K |
$7.95 | $9,982.40 | +32.25% | 5.15K |
Jun 15
| |||||||
Columbia Laboratories Inc
| 4.57K |
$0.01 | $45.66 | +117.35% | 8.46K |
May 8
| |||||||
Columbia Laboratories Inc
| 3.89K |
$7.71 | $29,999.61 |
∞
| 3.89K |
Sep 12
| |||||||
Columbia Laboratories Inc
|
0
|
—
|
—
|
—
|
0
| ||||||||
Curagen Corp
| -35.00K |
$0.91 | -$31,678.50 | -8.55% | 374.59K |
May 1
| |||||||
Curagen Corp
| -23.00K |
$0.73 | -$16,856.70 | -5.32% | 409.59K |
Feb 11
| |||||||
Curagen Corp
| 3.4K |
$1.33 | $4,524.04 | +0.54% | 632.59K |
Aug 10
| |||||||
Curagen Corp
| 200K |
—
|
—
| +46.60% | 629.19K |
May 25
| |||||||
Curagen Corp
| 129.19K |
—
|
—
| +43.06% | 429.19K |
Jan 24
| |||||||
Curagen Corp
| 300K |
—
|
—
|
∞
| 300K |
Mar 29
| |||||||
Innovate Oncology, Inc.
|
0
|
—
|
—
|
—
|
0
| ||||||||
Curagen Corp
|
0
|
—
|
—
|
—
|
0
|
May 4
| |||||||
Curagen Corp
|
0
|
—
|
—
|
—
|
0
|
Mar 15
| |||||||
Curagen Corp
|
0
|
—
|
—
|
—
|
0
| ||||||||
It looks like there's no data for these filter options. Maybe you'll be interested in these options instead. |